Penny Stocks on Move: MultiCell Technologies, Inc., TRANZBYTE CORPORATIO, MediSwipe Inc., Bio Matrix Scientific Group Inc.

Lakeway, NY -- (SBWIRE) -- 02/20/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

MultiCell Technologies, Inc. (PINK: MCET) slipped 16.33% to $0.0041 on a traded volume of 178.87 million shares. So far this year, the stock is up over 241%. The 52-week range for the stock is $0.0 and $0.01.

Get Latest News, Updates on MCET Here

TRANZBYTE CORPORATIO (PINK: ERBB) moved down 23.53% to $0.0078 on a traded volume of 92.66 million shares. Altitude Organic Corporation, a division of Tranzbyte Corporation announced the findings of research conducted by the company's soil development partner, U-mate International Inc.

Is ERBB a Strong Buying Opportunity After The Recent Gain? Find out Here

MediSwipe Inc. (PINK: MWIP) slipped 29.51% to $0.0726 on a traded volume of 15.53 million shares. The Company announced after the trading session on February 19th, the state of Michigan introduced new proposed legislation titled as House Bill 4271 outlining new requirements for Michigan's medical marijuana statewide program. MediSwipe Inc., formerly Cannabis Medical Solutions Inc. offers a transaction processing and security solutions for the medical and healthcare industries, using traditional, Internet Point-of-Sale, e-commerce and mobile payment solutions.

Is MWIP Signaling a Buy After The Solid gain? Don’t Miss Out Free Trend Analysis Here

Bio Matrix Scientific Group Inc. (PINK: BMSN) slipped 1.06% to $0.0093 on a traded volume of 84.16 million shares. Recently, Regen BioPharma a wholly-owned subsidiary of Bio-Matrix Scientific Group Inc. announced filing of an Investigational New Drug application with the FDA to initiate clinical trials assessing the company's HemaXellerate I™ stem cell drug in patients with drug-refractory aplastic anemia. The Company is in the business of designing, developing and marketing medical devices, specifically disposable instruments used in stem cell extraction and tissue transfer procedures and operating cryogenic cellular storage facilities, specifically stem cell banking facilities.

Is BMSN a Strong Buying Opportunity After The Recent Surge? Get Free Trend Analysis Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.